… FDA) – from fast-tracking lifesaving therapies, approving a record number of generics … . Kennedy Jr. and FDA Commissioner Marty Makary has … disrupted the FDA’s functionality, destabilized … survive into adulthood. The FDA only partially reversed this …

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all be documented. Fast-forward to this year, and the plant …

… generics, many from India and China. ProPublica previously disclosed that the FDA … public health, the FDA must protect sensitive … a crucial detail. Drug companies often have multiple plants, … July, newly named FDA Commissioner Marty Makary promised …

… the world to receive affordable generics and biosimilars.  Instead of … a rigged system that lets drug companies exploit patents, block competition, … and Purple Book are FDA databases that provide limited … their patents to the FDA and such disclosures should …

… from day one, navigating the FDA approval process proved more challenging … years to get our first FDA clearance," Warier admitted. … the West, India has branded generics… for every medicine, we have …

… earn U.S. FDA approval for a biosimilar … spectrum of services spans pharmaceuticals, specialty chemicals, and … It focuses on specialty pharmaceuticals and advanced Active Pharmaceutical … producing high-value, complex generics that bridge important treatment …

… topple access barriers to Vertex Pharmaceuticals’ potentially lifesaving, yet often out … can legally manufacture and export generics of patented drugs, the buyers … ’t been approved by the FDA. On the other hand, certain …

… into the benefits of repurposing generics, like ivermectin, to fight cancer … head lice and scabies. The FDA has not approved the use …

… billion to acquire Avadel Pharmaceuticals. Gilead subsidiary Kite … . BiomX announced new FDA feedback potentially expanding BX004 … for ongoing issues the generics manufacturer has failed … 22.4 million. Citius Pharmaceuticals announced a registered direct …

… new GLP-1 molecules and generics. And we expect this market … seals, stoppers and plungers. And generics revenue increased 2.6% organically … number of approvals by the FDA might be a little bit … . There’s an element around generics that were also able to …